• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

痴呆症的基因检测——实用性和临床策略。

Genetic testing in dementia - utility and clinical strategies.

机构信息

MRC Prion Unit at UCL, UCL Institute of Prion Diseases, London, UK.

South West Thames Regional Genetics Service, London, UK.

出版信息

Nat Rev Neurol. 2021 Jan;17(1):23-36. doi: 10.1038/s41582-020-00416-1. Epub 2020 Nov 9.

DOI:10.1038/s41582-020-00416-1
PMID:33168964
Abstract

Techniques for clinical genetic testing in dementia disorders have advanced rapidly but remain to be more widely implemented in practice. A positive genetic test offers a precise molecular diagnosis, can help members of an affected family to determine personal risk, provides a basis for reproductive choices and can offer options for clinical trials. The likelihood of identifying a specific genetic cause of dementia depends on the clinical condition, the age at onset and family history. Attempts to match phenotypes to single genes are mostly inadvisable owing to clinical overlap between the dementias, genetic heterogeneity, pleiotropy and concurrent mutations. Currently, the appropriate genetic test in most cases of dementia is a next-generation sequencing gene panel, though some conditions necessitate specific types of test such as repeat expansion testing. Whole-exome and whole-genome sequencing are becoming financially feasible but raise or exacerbate complex issues such as variants of uncertain significance, secondary findings and the potential for re-analysis in light of new information. However, the capacity for data analysis and counselling is already restricting the provision of genetic testing. Patients and their relatives need to be given reliable information to enable them to make informed choices about tests, treatments and data sharing; the ability of patients with dementia to make decisions must be considered when providing this information.

摘要

在痴呆症领域,临床遗传学检测技术已经取得了快速的发展,但在实际应用中仍有待进一步推广。阳性基因检测可提供精确的分子诊断,有助于受影响家族成员确定个人风险,为生殖选择提供依据,并为临床试验提供选择。确定痴呆症具体遗传病因的可能性取决于临床情况、发病年龄和家族史。由于痴呆症之间存在临床重叠、遗传异质性、多效性和并发突变,尝试将表型与单个基因相匹配是不可取的。目前,在大多数痴呆症病例中,适当的基因检测是下一代测序基因面板,尽管某些情况下需要特定类型的检测,如重复扩展检测。外显子组和全基因组测序在经济上变得可行,但却引发或加剧了一些复杂问题,如意义不明的变异、次要发现以及根据新信息重新分析的可能性。然而,数据分析和咨询的能力已经限制了基因检测的提供。需要向患者及其亲属提供可靠的信息,以使他们能够就检测、治疗和数据共享做出明智的选择;在提供这些信息时,必须考虑到痴呆症患者做出决策的能力。

相似文献

1
Genetic testing in dementia - utility and clinical strategies.痴呆症的基因检测——实用性和临床策略。
Nat Rev Neurol. 2021 Jan;17(1):23-36. doi: 10.1038/s41582-020-00416-1. Epub 2020 Nov 9.
2
Genetic screening in early-onset dementia patients with unclear phenotype: relevance for clinical diagnosis.早发性痴呆患者表型不明确的遗传筛查:对临床诊断的相关性。
Neurobiol Aging. 2018 Sep;69:292.e7-292.e14. doi: 10.1016/j.neurobiolaging.2018.04.015. Epub 2018 May 9.
3
Next Generation Sequencing Analysis in Early Onset Dementia Patients.下一代测序分析在早发性痴呆患者中的应用。
J Alzheimers Dis. 2019;67(1):243-256. doi: 10.3233/JAD-180482.
4
Validation of next-generation sequencing technologies in genetic diagnosis of dementia.下一代测序技术在痴呆症遗传诊断中的验证。
Neurobiol Aging. 2014 Jan;35(1):261-5. doi: 10.1016/j.neurobiolaging.2013.07.017. Epub 2013 Aug 31.
5
Genetic Analysis of Chinese Patients with Early-Onset Dementia Using Next-Generation Sequencing.采用新一代测序技术对中国早发性痴呆患者进行遗传分析。
Clin Interv Aging. 2020 Oct 2;15:1831-1839. doi: 10.2147/CIA.S271222. eCollection 2020.
6
Identification of rare genetic variants in Italian patients with dementia by targeted gene sequencing.通过靶向基因测序鉴定意大利痴呆症患者的罕见遗传变异。
Neurobiol Aging. 2018 Jun;66:180.e23-180.e31. doi: 10.1016/j.neurobiolaging.2018.02.006. Epub 2018 Feb 13.
7
Genetic testing and counseling in the diagnosis and management of young-onset dementias.年轻起病型痴呆症诊断与管理中的基因检测与咨询
Psychiatr Clin North Am. 2015 Jun;38(2):295-308. doi: 10.1016/j.psc.2015.01.008. Epub 2015 Mar 18.
8
Clinical application of whole genome sequencing in young onset dementia: challenges and opportunities.全基因组测序在早发性痴呆中的临床应用:挑战与机遇。
Expert Rev Mol Diagn. 2024 Aug;24(8):659-675. doi: 10.1080/14737159.2024.2388765. Epub 2024 Aug 12.
9
Predictors for a dementia gene mutation based on gene-panel next-generation sequencing of a large dementia referral series.基于大型痴呆症转诊队列基因 panel 下一代测序的痴呆症基因突变预测因素
Mol Psychiatry. 2020 Dec;25(12):3399-3412. doi: 10.1038/s41380-018-0224-0. Epub 2018 Oct 2.
10
An ESHG-ESHRE survey on the current practice of expanded carrier screening in medically assisted reproduction.ESHG-ESHRE 关于在医学辅助生殖中进行扩展携带者筛查的现行实践的调查。
Hum Reprod. 2024 Aug 1;39(8):1844-1855. doi: 10.1093/humrep/deae131.

引用本文的文献

1
Special Issue: The Role of Genetics in Dementia.特刊:遗传学在痴呆症中的作用
Int J Mol Sci. 2025 Aug 28;26(17):8355. doi: 10.3390/ijms26178355.
2
HTT loss-of-function contributes to RNA deregulation in developing Huntington's disease neurons.亨廷顿蛋白功能丧失导致亨廷顿病神经元发育过程中的RNA失调。
Cell Biosci. 2025 Jul 9;15(1):100. doi: 10.1186/s13578-025-01443-5.
3
A mini review of transforming dementia care in China with data-driven insights: overcoming diagnostic and time-delayed barriers.利用数据驱动的见解转变中国痴呆症护理的小型综述:克服诊断和时间延迟障碍

本文引用的文献

1
Cognitive profiles discriminate between genetic variants of behavioral frontotemporal dementia.认知特征可区分行为性额颞叶痴呆的遗传变异。
J Neurol. 2020 Jun;267(6):1603-1612. doi: 10.1007/s00415-020-09738-y. Epub 2020 Feb 12.
2
Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study.在一项 5000 人的神经病理学研究中,APOE2 纯合子患阿尔茨海默病痴呆的可能性极低。
Nat Commun. 2020 Feb 3;11(1):667. doi: 10.1038/s41467-019-14279-8.
3
Genetic screening of a large series of North American sporadic and familial frontotemporal dementia cases.
Front Aging Neurosci. 2025 Mar 3;17:1554834. doi: 10.3389/fnagi.2025.1554834. eCollection 2025.
4
Prevalence of Pathogenic Variants and Eligibility Criteria for Genetic Testing in Patients Who Visit a Memory Clinic.记忆门诊患者的致病基因变异患病率及基因检测的 eligibility 标准。 注:这里“eligibility”直译为“资格、合格性”,结合语境可能不太好理解其准确意思,或许原文此处有更合适的表述。
Neurology. 2025 Feb 25;104(4):e210273. doi: 10.1212/WNL.0000000000210273. Epub 2025 Jan 27.
5
Huntington's disease phenocopy syndromes revisited: a clinical comparison and next-generation sequencing exploration.亨廷顿舞蹈病表型模拟综合征再探讨:临床比较与二代测序探索
J Neurol Neurosurg Psychiatry. 2025 Apr 10;96(5):466-469. doi: 10.1136/jnnp-2024-333602.
6
Disparities in Genetic Testing for Neurologic Disorders.神经疾病基因检测中的差异。
Neurology. 2024 Mar 26;102(6):e209161. doi: 10.1212/WNL.0000000000209161. Epub 2024 Mar 6.
7
Expanding the phenotype of psychiatric-onset prodromal dementia with Lewy bodies.扩大伴有路易小体的精神性起病前驱期痴呆的表型。
J Neurol. 2024 Apr;271(4):2125-2128. doi: 10.1007/s00415-023-12161-8. Epub 2024 Jan 3.
8
Genetic testing in adults with neurologic disorders: indications, approach, and clinical impacts.成人神经障碍的基因检测:适应证、方法及临床影响。
J Neurol. 2024 Feb;271(2):733-747. doi: 10.1007/s00415-023-12058-6. Epub 2023 Oct 27.
9
Whole genome sequencing identifies genetic variants associated with neurogenic inflammation in rosacea.全基因组测序鉴定出与酒渣鼻神经炎症相关的遗传变异。
Nat Commun. 2023 Jul 5;14(1):3958. doi: 10.1038/s41467-023-39761-2.
10
Clinical considerations in early-onset cerebral amyloid angiopathy.早发性脑淀粉样血管病的临床注意事项。
Brain. 2023 Oct 3;146(10):3991-4014. doi: 10.1093/brain/awad193.
对大量北美散发性和家族性额颞叶痴呆病例进行遗传筛查。
Alzheimers Dement. 2020 Jan;16(1):118-130. doi: 10.1002/alz.12011.
4
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study.遗传性额颞叶痴呆的发病年龄和死亡年龄以及疾病持续时间:一项国际回顾性队列研究。
Lancet Neurol. 2020 Feb;19(2):145-156. doi: 10.1016/S1474-4422(19)30394-1. Epub 2019 Dec 3.
5
Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report.载脂蛋白 E3 基督城纯合子对常染色体显性阿尔茨海默病的抗性:一例报告。
Nat Med. 2019 Nov;25(11):1680-1683. doi: 10.1038/s41591-019-0611-3. Epub 2019 Nov 4.
6
Genetic Factors in Mammalian Prion Diseases.哺乳动物朊病毒病的遗传因素。
Annu Rev Genet. 2019 Dec 3;53:117-147. doi: 10.1146/annurev-genet-120213-092352. Epub 2019 Sep 19.
7
Ageing as a risk factor for neurodegenerative disease.衰老作为神经退行性疾病的一个风险因素。
Nat Rev Neurol. 2019 Oct;15(10):565-581. doi: 10.1038/s41582-019-0244-7. Epub 2019 Sep 9.
8
Cellular and regional vulnerability in frontotemporal tauopathies.额颞叶tau 病的细胞和区域易损性。
Acta Neuropathol. 2019 Nov;138(5):705-727. doi: 10.1007/s00401-019-02035-7. Epub 2019 Jun 15.
9
Profiling the genome-wide landscape of tandem repeat expansions.全基因组串联重复扩展图谱分析。
Nucleic Acids Res. 2019 Sep 5;47(15):e90. doi: 10.1093/nar/gkz501.
10
Long-Read Sequencing Emerging in Medical Genetics.长读长测序在医学遗传学中崭露头角。
Front Genet. 2019 May 7;10:426. doi: 10.3389/fgene.2019.00426. eCollection 2019.